As shown in the results of the transwell invasion experiment in Figure 10C, the number of invasive cells following siNDC80 treatment of human glioblastoma cells (U251, U118, and A172) was significantly lower than that of the control group, indicating that downregulation of NDC80 protein significantly inhibited the invasive ability of glioblastoma cells. Here, NDC80 is linked to glioblastoma.